Clinical Trial Update: Analysis of Birth Outcomes of Swedish, Danish and Finnish Women Exposed to Remicade With Inflammatory Bowel Disease, Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, and Psoriasis

View source ↗

Summary

A completed analysis of birth outcomes among Swedish, Danish, and Finnish women exposed to Remicade (infliximab) during pregnancy across inflammatory bowel dise…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis
• Inflammatory Bowel Disease
• Psoriasis
• Psoriatic Arthritis
• Rheumatoid Arthritis

Drugs mentioned

• Remicade (infliximab)

Snippet

Sponsor: Janssen Biotech, Inc. | Conditions: Inflammatory Bowel Disease | Status: COMPLETED